 |
|
|
 |
|
Rationale:
- In mildly poisoned patients, once symptoms and HbCO return to normal, significant future cellular toxicity is unlikely and
further oxygen therapy is probably not beneficial.
|
|
Evidence:
- In a randomized clinical trial, 307 patients were treated with either HBOT or NBOT and only patients with headache or dizziness
were at risk of developing persistent or delayed-onset neurologic symptoms, whereas other patients in both groups lacked sequelae
(42).
|
|
Comments:
|
| FAQs |
|
|
|
Jeffrey T. Chapman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Carbon Monoxide Poisoning
> Hospitalization
